Company Profile
Description
PEAL Capital Partners is a female-founded, lower midcap private equity firm specializing in control investments within the rapidly growing sector of Longevity and Hormones (“L&H”). The senior team have worked together since 2006 and built up a strong track record of repositioning companies for growth across multiple economic cycles and regions. Headquartered in Switzerland, we have offices in London and Dublin.
Number of employees in Switzerland
8
Capital under Management
USD 120m
Fund Names
PEAL Capital Fund
Number of Portfolio Companies
4
Examples of Portfolio Companies
Derma Med Ltd - Medical Training
Year of Establishment
2022
Investments
Type of Firm
Fund Management Company
Investment Stages
Buyout - Buyin, Turnaround - Restructuring
Industrial Sectors
Medical - Life Sciences - Health Related
Geographical Focus
North America, Western Europe
Type of Financing
Majority Equity, Minority Equity
Investment preferences
Size of Investment
-
Funds available to invest
-
Minimum investment considered
-
Maximum investment considered
-
